Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of … M Correction Naghavi, H Wang, R Lozano, A Davis, X Liang, M Zhou, ... The Lancet 385 (9963), 117-171, 2015 | 5745 | 2015 |
Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 1: Burden of disease from CRS. FT Cutts, SE Robertson, JL Diaz-Ortega, R Samuel Bulletin of the world Health Organization 75 (1), 55, 1997 | 406 | 1997 |
Dissonant health transition in the states of Mexico, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 H Gómez-Dantés, N Fullman, H Lamadrid-Figueroa, L Cahuana-Hurtado, ... The Lancet 388 (10058), 2386-2402, 2016 | 291 | 2016 |
Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 2: Vaccination against rubella. SE Robertson, FT Cutts, R Samuel, JL Diaz-Ortega Bulletin of the World Health Organization 75 (1), 69, 1997 | 276 | 1997 |
Gene expression profiles and structural/functional features of the peri-implantation endometrium in natural and gonadotropin-stimulated cycles S Mirkin, G Nikas, JG Hsiu, J Díaz, S Oehninger The Journal of Clinical Endocrinology & Metabolism 89 (11), 5742-5752, 2004 | 274 | 2004 |
Immunization of six-month-old infants with different doses of Edmonston–Zagreb and Schwarz measles vaccines LE Markowitz, J Sepulveda, JL Diaz-Ortega, JL Valdespino, P Albrecht, ... New England journal of medicine 322 (9), 580-587, 1990 | 221 | 1990 |
Recommended childhood immunization schedule--United States, 2001 Centers for Disease Control and Prevention (CDC MMWR. Morbidity and mortality weekly report 50 (1), 7-19, 2001 | 128 | 2001 |
Results of in vitro fertilization attempts in women 40 years of age and older: the Norfolk experience A Romeu, SJ Muasher, AA Acosta, LL Veeck, J Diaz, GS Jones, ... Fertility and sterility 47 (1), 130-136, 1987 | 126 | 1987 |
Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: a nationwide descriptive study M García-Grimshaw, LE Hernández-Vanegas, I Núñez, ... Clinical Immunology 229, 108786, 2021 | 114 | 2021 |
Índice y sinonimia de las plantas medicinales de México JL Díaz (No Title), 1976 | 105 | 1976 |
Cultura tributaria J Díaz, B Cruz, N Castillo Revista publicando 3 (9), 697-705, 2016 | 100 | 2016 |
Cobertura de vacunación en niños y adolescentes en México: esquema completo, incompleto y no vacunación JL Díaz-Ortega, E Ferreira-Guerrero, B Trejo-Valdivia, MM Téllez-Rojo, ... salud pública de méxico 55, S289-S299, 2013 | 67* | 2013 |
From state-to-trait meditation: Reconfiguration of central executive and default mode networks CCC Bauer, S Whitfield-Gabrieli, JL Díaz, EH Pasaye, FA Barrios Eneuro 6 (6), 2019 | 59 | 2019 |
Cost-effectiveness of measles elimination in Latin America and the Caribbean: a prospective analysis A Acharya, JL Diaz-Ortega, G Tambini, C de Quadros, I Arita Vaccine 20 (27-28), 3332-3341, 2002 | 53 | 2002 |
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score British journal of surgery 108 (11), 1274-1292, 2021 | 48 | 2021 |
Cobertura de vacunación y proporción de esquema incompleto en niños menores de siete años en México JL Díaz-Ortega, LP Cruz-Hervert, E Ferreira-Guerrero, LD Ferreyra-Reyes, ... salud pública de méxico 60 (3), 338-346, 2018 | 47 | 2018 |
Missed opportunities for vaccination in the Dominican Republic: results of an operational investigation Z Garib, AL Vargas, SP Trumbo, K Anthony, JL Diaz-Ortega, ... BioMed research international 2016 (1), 4721836, 2016 | 45 | 2016 |
A systematic review of rubella vaccination strategies implemented in the Americas: impact on the incidence and seroprevalence rates of rubella and congenital rubella syndrome N Mongua-Rodriguez, JL Díaz-Ortega, L García-García, M Piña-Pozas, ... Vaccine 31 (17), 2145-2151, 2013 | 40 | 2013 |
Análisis de la evidencia sobre eficacia y seguridad de la vacuna de dengue CYD-TDV y su potencial registro e implementación en el Programa de Vacunación Universal de México M Hernández-Ávila, E Lazcano-Ponce, JE Hernández-Ávila, ... salud pública de méxico 58 (1), 71-83, 2016 | 39* | 2016 |
Lessons learned from the development of a new methodology to assess missed opportunities for vaccination in Latin America and the Caribbean M Velandia-González, SP Trumbo, JL Díaz-Ortega, P Bravo-Alcántara, ... BMC international health and human rights 15, 1-8, 2015 | 38 | 2015 |